🚨 Final Extension!
For all last-minute decision-makers: We’ve extended the registration and abstract submission deadline for the EUPLAN (European Platelet Network) Conference in Würzburg to Wednesday, July 9.
platelets.eu/euplan2025/#EUPLAN2025#Platelets#Hematology
Heading to #Würzburg this September? So are Florian Gärtner, Kathleen Freson (@KathleenFreson) & Alice Assinger (@PlateletVienna)!
Catch their keynotes at #EUPLAN2025, Sept 19 (Day 3).
Join the conversation on the future of platelet and megakaryocyte research.
It was an amazing #megakaryocytes#platelets@GordonConf in Ventura, CA!
✅️Our data/project presented!
✅️Power Hour organized with the great @DrKoupenova .
✅️Met fantastic colleagues
✅️ Interesting discussions
Thank you for the organization @YotisSenis and Renhao Li!
#GTH2025 in Lausanne 🇨🇭69th Annual Meeting of the Society of Thrombosis and Haemostasis Research. Motto: ARTE - latest insights into Advances, Research, Technology and Education in the field of Thrombosis and Haemostasis.
"Advanced course in platelet research" in Murcia has come to an end! Two days of fantastic science and amazing food! Thanks to @JosRiveraPozo2 for organizing this meeting! @isth#SETH#platelets#megakaryocytes
Congrats 👏🏼Further information on this great project about PITT - platelet-derived integrin- and tetraspanin-enriched tethers - can be found here, in English:
idw-online.de/de/news831786
and in German: ukw.de/aktuelle-meldungen/de…
ALT The PITTs - platelet-derived integrin- and tetraspanin-enriched tethers - observed here in the mouse by Bernhard Nieswandt are comet-tail-like organelles shed by platelets that interact with other cells in the vascular system modulate their function and thereby fuel inflammation and tissue damage.
Thrilled to announce that our PiTT-inflame project studying #thrombo-inflammation has been honored with an ERC Advanced Grant @ERC_Research !🎆
Thanks a lot to all past and present members for their outstanding work on this exciting project!👏
Herzlichen Glückwunsch an Bernhard Nieswandt @NieswandtLab. Für seine Pionierarbeit in der Blutplättchenforschung und seine neueste Entdeckung wurde er jetzt mit einem ERC Advanced Grant @ERC_Research in Höhe von 2,5 Millionen Euro ausgezeichnet ➡️ukw.de/aktuelle-meldungen/de…
ALT Prof. Dr. Bernhard Nieswandt, Leiter des Lehrstuhls für Experimentelle Biomedizin I am Uniklinikum Würzburg (UKW), und Forschungsgruppenleiter am Rudolf-Virchow-Zentrum (RVZ) der Universität Würzburg (JMU), erhält den prestigeträchtigen ERC Advanced Grant für seine Forschung zu einem noch gänzlich unbekannten zellulären Mechanismus in Thrombozyten. Eigentlich ist das Leben eines Thrombozyten nach seiner Aktivierung und Anhaftung an Verletzungsstellen schnell vorbei, und er wird von Phagozyten entsorgt. Doch wir konnten sehen, dass nicht aktivierte Thrombozyten im Blutstrom einen unerwarteten Prozess zellulärer Reorganisation durchlaufen, der dazu führt, dass sie Teile ihrer Membran dort deponieren, wo Entzündungsprozesse ablaufen und diese damit befeuern.“
Thrilled to announce that our PiTT-inflame project studying #thrombo-inflammation has been honored with an ERC Advanced Grant @ERC_Research !🎆
Thanks a lot to all past and present members for their outstanding work on this exciting project!👏
NEWS: We’re thrilled to announce that Wolfram Ruf has been elected as ISTH President for the 2026-2028 term. Please join us in congratulating him!🎊
@scrippsresearch